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Elevated manganese levels in blood and central nervous system occur before
onset of clinical signs in scrapie and bovine spongiform encephalopathy
S. Hesketh,* J. Sassoon,* R. Knight,† J. Hopkins,‡ and D. R. Brown*1
*Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AY, UK; †Department
of Chemistry, University of Hull, Hull HU6 7RX, UK; and ‡Division of Veterinary
Biomedical Sciences, University of Edinburgh, Edinburgh, EH9 1QH, UK
ABSTRACT: Prion diseases, or transmissible spongi-
form encephalopathies, are neurodegenerative diseases
that can only be accurately diagnosed by analysis of
central nervous system tissue for the presence of an
abnormal isoform of the prion protein known as PrPSc.
Furthermore, these diseases have long incubation peri-
ods during which there are no clear symptoms but
where the infectious agent could still be present in the
tissues. Therefore, the development of diagnostic
assays to detect a surrogate marker for the presence
of prion disease is essential. Previous studies on mice
experimentally infected with scrapie, an ovine spongi-
form encephalopathy, suggested that changes in the
levels of Mn occur in the blood and brain before the
onset of symptoms of the disease. To assess whether
these findings have relevance to the animal diseases
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INTRODUCTION
Prion diseases are fatal neurodegenerative condi-
tions characterized by high neuronal death in specific
regions of the central nervous system (CNS), gliosis,
and the deposition of an abnormal prion protein isoform
in CNS tissues (Prusiner, 1998). The different forms
of these diseases vary in terms of their pathology but
generally have long incubation periods. In humans,
there are sporadic forms of the disease such as Creutz-
feldt-Jakob disease (CJD), which has no known cause,
Gerstmann-Stra¨ussler-Scheinker syndrome, and forms
in which transmission has occurred between individu-
als such as kuru and variant CJD.
Prion diseases are also found in domesticated ani-
mals, such as scrapie in sheep and bovine spongiform
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scrapie and bovine spongiform encephalopathy, tissues
from bovine spongiform encephalopathy- and scrapie-
infected cattle and sheep were analyzed for their metal
content and compared with values for noninfected ani-
mals. In field cases and experimentally infected ani-
mals, elevated Mn was associated with prion infection.
Although some central nervous system regions showed
elevated Mn, other regions did not. The most consistent
finding was an elevation of Mn in blood. This change
was present in experimentally infected animals before
the onset of symptoms. In scrapie-infected sheep, ele-
vated Mn levels occurred regardless of the genotype of
the sheep and were even detected in scrapie-resistant
sheep in which no symptoms of disease were detected.
These findings suggest that elevated blood Mn could be
a potential diagnostic marker for prion infection even
in the absence of apparent clinical disease.
encephalopathy (BSE) in cattle. The origin of scrapie
is unknown, but it is considered to be a sporadic disease.
The origin of BSE is also unknown, but this disease
reached epidemic proportions due to the consumption
of rendered offal of prion disease-infected cattle by dairy
cattle in the late 1980s and 1990s (Anderson et al.,
1996). This epidemic spurred concern about rapid detec-
tion of this disease by noninvasive techniques.
Diagnosis of prion disease is currently only possible
postmortem. Although a number of diagnostic criteria
allow a probable diagnosis of the disease, a confirmation
of this requires analysis of CNS tissue for the presence
of PrPSc, the protease-resistant abnormal isoform of
the prion protein, PrPc, which is expressed by neurons
(Sales et al., 1998), particularly at the synapse, and is
a Cu-binding protein (Hornshaw et al., 1995; Brown et
al., 1997, 2000; Thompsett et al., 2005). Although there
is strong evidence that this protein is an antioxidant
(Brown et al., 1999, 2001), the finding is still disputed
(Hutter et al., 2003; Jones et al., 2005). Conversion of
PrPc to PrPSc results in a conformational change from
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a helical form to one rich in beta sheets, and exhibiting
increased protease resistance, altered metal binding,
and possible loss of function. It is the protease resis-
tance of PrPSc that forms the basis of most diagnostic
tests.
The necessity for postmortem tissue for a definitive
diagnosis has fueled the search for other ways to detect
prion disease in tissue that can be collected or biopsied
before death. Amplification of the level of PrPSc in brain
or heart tissues has been successfully accomplished by
a cyclic method (Saborio et al., 2001; Castilla et al.,
2005). Unfortunately, the application of this technique
is limited by the need for normal brain or heart tissue.
An effective test could potentially use changes in the
level of a surrogate marker (Miele et al., 2001; Parveen
et al., 2005; Van Everbroeck et al., 2005). Although
some markers have been investigated, only the protein
14-3-3 has been shown to be of benefit in detecting CJD
(Hsich et al., 1996). Because conversion of PrPc to PrPSc
results in a loss of Cu binding to the protein, changes in
metals in the brain have been investigated. In scrapie-
infected mice and humans with CJD, the levels of Mn
have been shown to be increased in the brain (Wong et
al., 2001; Thackray et al., 2002). In parallel, there was
a loss of Cu binding to the PrP and an increase in Mn
associated with affinity isolated PrP. Binding of Mn to
the PrP results in a change in its conformation (Brown
et al., 2000; Tsenkova et al., 2004). In scrapie-infected
mice, an increase in blood levels of Mn has been shown
to occur even before the onset of symptoms (Thackray
et al., 2002). Metal levels in sheep and cattle have not
been studied in detail with modern techniques.
We therefore studied metal levels of sheep and cattle
with prion diseases compared with those in control ani-
mals. The levels were monitored in field cases of scrapie
and BSE and in animals experimentally challenged
with BSE or scrapie.
METHODS
Unless stated otherwise all reagents were purchased
from Sigma (Poole, UK). All procedures involving ani-
mals were approved by the UK Home Office.
Animal Tissues
Tissue and blood samples of field cases of cattle with
BSE and sheep with scrapie were supplied by the Veter-
inary Laboratories Agency. The BSE and scrapie cases
were from fallen stock reported to the agency and diag-
nosed with transmissible spongiform encephalopathies
(TSE) after postmortem analysis for the presence of
abnormal prion protein. Controls used for these studies
were from fallen stock suspected of having a TSE but
confirmed not to have these diseases.
Experimental BSE Infection
Tissues were taken from cattle experimentally chal-
lenged orally with 100 g of BSE-infected brain. The
cattle were 3 to 5 mo of age at the time of challenge.
These cattle were challenged with BSE for the produc-
tion of archivable tissue samples as part of a Depart-
ment of the Environment, Food, and Rural Affairs (DE-
FRA)-funded project (SE1736). Age-matched controls
and BSE-infected cattle of similar age were culled at
specific time points from the time of infection, through
the incubation period of the disease, and up to the termi-
nal stages of the BSE disease process. Tissues were
taken from the spinal cord, frontal cortex, liver, and
triceps brachii muscle. The samples were no more than
1 g in size. Blood samples were also collected, and hepa-
rin was added to preserve them. The BSE-challenged
cattle first showed sign of BSE symptoms at approxi-
mately 24 mo after exposure (27 to 29 mo of age). Classi-
cal BSE histopathology and PrPSc deposition were con-
firmed from brain samples of the animals that were
culled at 30 mo after exposure.
Experimental Scrapie Infection
Three groups of yearling New Zealand Cheviot sheep
(the DEFRA/SF flock), with defined PrP (loci 136, 154,
and 171) genotype (Houston et al., 2002), were used
for experiments (BBSRC-funded project 15/BS516875).
These were as follows:
Group 1, VRQ/VRQ short incubation period (150 ± 11 d);
Group 2, VRQ/ARR intermediate incubation period
(259 ± 9 d); and
Group 3, ARR/ARR nonsusceptible.
The sheep were infected by subcutaneous injection
with SSBP/1 scrapie (5 mL of a 10% SSBP/1 homoge-
nate, 0.5 g of brain per challenged sheep) or an equiva-
lent quantity of uninfected brain homogenate. Three
infected and 2 uninfected animals were killed by exsan-
guination under terminal barbiturate anesthesia; se-
quentially at 10, 25, 50, 75, 100, and 125 d after infec-
tion (all 3 groups); and at 150 and 230 d (groups 2
and 3).
Sample Digestion and Mass Spectroscopy
Samples of CNS tissue, liver, and muscle were di-
gested in a MARS 5 microwave digester (CEM, Mat-
thews, NC). Samples were no more than 1 to 2 g in size.
Samples were placed in tephlon digestion capsules with
5 to 10 mL of concentrated nitric acid (SPA grade,
Romil, Cambridge, UK) and left to equilibrate over-
night. The digestion was then carried out using a 10-
min ramping phase to reach 180°C and a pressure not
exceeding 225 psi. The samples were digested for 10
min and allowed to cool. The resultant digests were
clear when diluted to 1:5 (vol/vol) with water (UHQ
grade, ELGA, High Wycombe, UK) and were stored in
new plastic sample tubes.
Blood samples were digested with tetramethyl am-
monium hydroxide (TMAH; Alfa Aesar, Heysham, UK)
that was mixed at a ration of 2 parts of TMAH with 1
part blood (vol/vol). The samples were left for at least
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2 wk before analysis. A solution containing 1.0 g/L of
EDTA in 10 mL/L of TMAH solution described above
and 1 mL/L of Triton-X surfactant in water was added
to aid retention of the metals in solution and to dilute
each TMAH-blood sample 5-fold.
A Perkin Elmer (Milan, Italy), Elan DRCII, induc-
tively coupled plasma mass spectroscopy instrument
was used for the analysis of Mn, Ni, Cu, Zn, Se, and
Mo. Quantitative multielement calibrations were made
using standards diluted in a suitable matrix from certi-
fied, single element, 1,000 ppm, standard solutions at
concentration ranges to suit the samples. The blood
solutions were aspirated for 60 s before analyzing for
3 replicates and then washed in the blank alkaline
sample matrix between solutions. A 10 ppb solution of
Ga in the alkaline matrix was mixed with the sample
stream to monitor the instrument performance, and a
standard check solution was analyzed after each set of
10 samples. The nitric-acid tissue digests were analyzed
in a similar way, using the matched nitric acid matrix
for the standards, wash, and the internal standard.
A Perkin Elmer Optima 5300DV emission inductively
coupled plasma mass spectroscopy instrument was also
used for the analysis of Fe and Zn. The recommended
emission wavelengths (Fe, 238.204 nm; Zn, 206.200 nm;
according to the manufacturer) were used; the analysis
was matrix matched depending on whether they were
brain tissue digests or blood; and calibrations were
made at suitable ranges to match the sample solutions.
Analysis was in axial view mode, and 3 replicates were
made for each measurement. Standard checks every 10
samples were used to monitor the analysis.
Calibrations were acceptably linear. Correlation coef-
ficients better than 0.999 and results for metal concen-
trations in solution were corrected for the dilution from
the original to give the results reported. Detection lim-
its were defined as 3 times the SD of the mean of the
blank solutions analyzed.
Statistical Analysis
Analysis of the field samples was simpler than for
the experimental TSE cases, and the number of samples
was small. For this reason, a 2-tailed Student’s t-test
was used. For statistical analysis of experimental BSE,
experimental scrapie, and the matching controls, AN-
OVA was used. The exception was for analysis of
scrapie-infected sheep blood samples, where compari-
sons between time points were made. For these analy-
ses, an unpaired t-test was used. A comparison was
considered significant only ifP < 0.05. It should be noted
that samples were collected from different animals, and




The metal content of whole blood and CNS from cows
and sheep was assessed using mass spectroscopy. The
concentrations of the metals Cu, Mn, Mo, Zn, Fe, and
Se were determined. As an initial assessment of metal
levels samples were obtained from field cases of BSE
and scrapie and compared with similar samples from
control animals that were verified as not having a TSE.
The samples were prepared from equivalent CNS re-
gions. The CNS samples were digested to atomic compo-
nents by microwave-mediated digestion in concentrated
nitric acid. Blood samples were hydrolyzed to atomic
components using concentrated alkali.
Table 1 shows the results from the analyses of CNS
components from sheep and cattle. For cattle, samples
of the frontal cortex, spinal cord, and brain stem were
analyzed. Most of the metals analyzed showed no differ-
ence when comparing BSE-infected animals and con-
trols. Control animals showed higher levels of Cu in all
3 regions. This suggests that BSE infection causes a
reduction of Cu levels throughout the CNS. Analysis of
Mn showed a significant increase in the spinal cord and
brain stem from BSE-infected cattle when compared
with controls. There was no increase in Mn in the fron-
tal cortex. This suggests that changes in Mn are re-
gion specific.
The frontal cortex, cerebellum, and brain stem of
sheep were analyzed for metal content. As with BSE,
scrapie-infected sheep showed a reduction in the level of
Cu compared with controls, again suggesting a general
trend in the CNS of prion-infected animals. Zinc and
Fe levels were not affected by scrapie infection. There
were more specific changes in the other metals. In the
cerebellum of scrapie-infected sheep there was a slight
but significant reduction in the levels of Se as well as
an increase in the level of Mo. The cerebellum and brain
stem showed an increase in the level of Mn. Once again
Mn showed a region-specific change.
Blood samples from BSE-infected cattle were also
analyzed (Table 2). The levels of Cu, Fe, and zinc were
unaffected when compared with controls. Levels of Mo
and Se were reduced in BSE-infected cattle. Levels of
Mn were increased significantly following BSE infec-
tion. These results suggest that BSE infection changes
the levels of specific metals. Levels of metals in blood
from sheep were also studied. The results seen were
similar to that for BSE except that scrapie infection
caused an increase in Cu levels. This change was small
but significant. The increase in Mn was smaller in
scrapie than in BSE but was still significant. These
studies show that, although TSE cause a change in
blood metal concentrations, some of the changes are
not universal.
Samples of cerebrospinal fluid from BSE cows and
scrapie-infected sheep were also assessed, but no sig-
nificant difference in the content of any of the metals
measured could be observed (data not shown).
Experimental BSE
Analysis of field cases of BSE or scrapie give a view
of metal status at the terminal stages of the disease
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Table 1.Metal concentrations in central nervous system (CNS) tissues from bovine spongi-
form encephalopathy (BSE) and scrapie field cases1
Item Mn (ppb) Cu (ppb) Fe (ppm) Zn(ppm) Se(ppb) Mo (ppb)
Cattle
Frontal cortex
Control 326 ± 34 4,651 ± 291 18 ± 6 9 ± 4 184 ± 35 61 ± 12
BSE 344 ± 22 3,636 ± 242* 17 ± 4 11 ± 3 190 ± 21 92 ± 8
Brain stem
Control 191 ± 15 4,576 ± 195 23 ± 5 11 ± 4 258 ± 41 19 ± 4
BSE 415 ± 57* 3,645 ± 340* 22 ± 5 13 ± 4 267 ± 39 21 ± 5
Spinal cord
Control 266 ± 36 3,367 ± 165 12 ± 3 14 ± 4 212 ± 28 28 ± 8
BSE 365 ± 26* 2,267 ± 170* 11 ± 3 13 ± 3 198 ± 31 31 ± 9
Sheep
Frontal cortex
Control 261 ± 21 3,523 ± 235 13 ± 3 12 ± 2 140 ± 17 20 ± 3
Scrapie 291 ± 38 2,658 ± 214* 13 ± 4 11 ± 2 129 ± 14 20 ± 3
Cerebellum
Control 323 ± 29 5,088 ± 367 18 ± 3 10 ± 1 317 ± 27 20 ± 3
Scrapie 418 ± 39* 3,059 ± 214* 19 ± 3 11 ± 2 248 ± 24* 33 ± 3*
Brain stem (Obex)
Control 365 ± 3 4,321 ± 345 16 ± 3 7 ± 2 214 ± 11 18 ± 3
Scrapie 521 ± 3* 3,245 ± 267* 16 ± 4 8 ± 2 248 ± 14 17 ± 3
1ppm = parts per million, ppb = parts per billion.
*Significantly different from control by Student’s t-test (P < 0.05). Shown are the mean and SE for 4
individuals for sheep and 5 to 6 animals for cattle.
but do not provide an insight into the changes that
occur during the disease process or before the onset of
disease symptoms. This study was benefited by access
to samples from a study of experimental BSE that re-
sulted in the archiving of tissues from BSE-infected
animals and age-matched uninfected controls from the
time of oral infection up until terminal stages of the
disease. With access to these tissues we were able to
make a comprehensive study of metal changes during
BSE infection. From the CNS, we studied spinal cord
and frontal cortex. As control tissues we used muscle
(triceps femoris) and liver. We also analyzed blood sam-
ples from the same animals. Mass spectroscopy was
used to determine the concentration of Cu, Mn, Zn, Fe,
Mo, and Se. The values (n = 50 to 60) for challenged
and unchallenged controls were plotted in Figures 1 to
5. Analysis of the differences between time points or
between controls and experimental subjects was carried
out using ANOVA. In order to simplify the analysis,
Table 2. Metal concentrations in whole blood from bovine spongiform encephalopathy
(BSE) and scrapie field cases
Item Mn (ppb) Cu (ppb) Fe (ppm) Zn (ppb) Se (ppb) Mo (ppb)
Cattle
Control 49 ± 5 1,651 ± 195 521 ± 70 4.0 ± 0.43 61 ± 35 95 ± 35
BSE 83 ± 12* 1,636 ± 340 569 ± 59 4.6 ± 0.41 98 ± 67* 20 ± 7*
Sheep
Control 32 ± 3 923 ± 67 23 ± 3 5.2 ± 0.45 12 ± 67 31 ± 3
Scrapie 40 ± 3* 1,220 ± 114* 38 ± 4 4.6 ± 0.43 48 ± 84* 19 ± 3*
*Significantly different to control by Student’s t-test (P < 0.05). Shown are the mean and SE for 5 to 6
individual animals.
values were grouped in terms of decamonth (dmth) of
life. Values were combined between 0 to 10 mo, 11 to
20 mo, 21 to 30 mo, 31 to 40 mo, and over 41 mo and
are henceforth referred to as the first, second, third,
fourth, and fifth dmth.
In the analysis of control frontal cortex values for
most metals indicated that between the first and fifth
dmth there is no significant change (Figure 1). The
only metal that changed significantly (P < 0.05) in the
controls throughout the period of study was Cu. In the
first dmth the average Cu concentration was 1.823 ±
0.512 ppm. This increased to 5.829 ± 0.723 ppm in the
fifth dmth. The other metals showed no significant dif-
ference over the age range. Therefore, combining all
ages gives the following values: Mn, 308 ± 12 ppb; Zn,
12 ± 0.4 ppm; Fe, 16 ± 1 ppm; Se, 265 ± 12 ppb; and
Mo, 48 ± 5 ppb. Differences between the control values
and BSE were similarly analyzed and also compared
with control values. Concentrations for Mn, Zn, Se, and
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Figure 1. Samples of frontal cortex from cattle infected with BSE () or age-matched controls () were digested to
atomic components and assessed formetal content using inductively coupled plasmamass spectroscopy. The individual
values were plotted to show the range of values for each time point. Concentrations of Cu (A), Mn (B), Zn (C), Se
(D), Mo (E), and Fe (F) are plotted according to the age of the animal at the time of culling. Values are either in parts
per billion (ppb) or parts per million (ppm). n = 9 to 14 for each decamonth. Arrowhead indicates approximate time
of onset of clinical signs.
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Fe showed no change in BSE animals with age and also
no significant difference to control values. The average
values for these metals were Mn, 314 ± 8 ppb; Zn, 13
± 1 ppm; Fe, 18 ± 2 ppm; and Se, 254 ± 17 ppb. Values
of Cu for BSE show no significant difference throughout
the time course of the experiment with an average value
of 2.248 ± 0.623 ppm. The BSE values for Cu were
significantly different (P < 0.05) to controls in the fifth
dmth (BSE value was 3.754 ± 0.623 ppm, control value
was 5,829 ± 723). Molybdenum in BSE showed an in-
crease with time. The average values over the 5 dmth
were first, 49 ± 4 ppb; second, 51 ± 5 ppb; third, 79 ± 6
ppb; fourth, 115 ± 16 ppb; and fifth, 123 ± 12 ppb.
The control values were significantly different from the
third dmth onward. The control values for Mo were
third, 51 ± 3 ppb; fourth, 53 ± 6 ppb; and fifth, 49 ± 5
ppb. These results suggest that BSE caused changes
in Cu and Mn in the frontal cortex.
Results from the analysis of spinal cord (Figure 2)
from cattle with BSE were also analyzed and compared
with controls from unchallenged animals. The control
values for Mn, Zn, Se, Mo, and Fe showed no significant
change throughout the experiment. The average values
for metals in the control animals were: Mn, 285 ± 27
ppb; Zn, 12 ± 2 ppm; Se, 151 ± 8 ppb; Mo, 28 ± 3 ppb;
and Fe, 9 ± 2 ppm. The Cu in the spinal cord was similar
to frontal cortex in that there was a significant increase
in Cu through the time course of the experiment. Con-
trol Cu values increased from 1.213 ± 0.245 ppm in
the first dmth to 3.567 ± 0.312 ppm in the fifth dmth.
Comparison of BSE-infected cattle to the controls indi-
cated that there was no significant difference in the
levels of Zn, Se, Mo, and Fe throughout the experiment.
The average values for these metals were Zn, 12 ± 2
ppm; Se, 163 ± 11 ppb; Mo, 29 ± 4 ppb; and Fe, 11 ± 3
ppm. For BSE-challenged animals there was a signifi-
cant difference in the level of Cu. This difference was
significant from the third dmth onward (BSE, 1.365 ±
0.243 ppm and control, 2.976 ± 0.365 ppm). This indi-
cates that BSE caused a significant decrease in Cu in
the spinal cord. The Mn showed a significant increase
in BSE spinal cord, when compared with controls, from
the third dmth onward. The values were third, 523 ±
72 ppb for BSE, 366 ± 85 for controls; fourth, 634 ± 123
ppb for BSE, 276 ± 54 ppb for controls; and fifth, 583
± 145 ppb for BSE, 276 ± 65 ppb for controls. The results
suggest that BSE alters the levels of Cu and Mn in the
spinal cord.
The metal content of the liver was analyzed for BSE-
infected cattle and compared with controls (Figure 3).
Levels of all metals did not change significantly
throughout the time course of the experiment in the
controls. The averages of all values measured were Cu,
31 ± 3 ppm; Mn, 2.3 ± 0.2 ppb; Zn, 0.65 ± 0.11 ppm; Se,
0.54 ± 0.09 ppb; Mo, 0.86 ± 0.12 ppb; and Fe, 1.35 ±
0.25 ppb. The BSE infection had no effect on most of
the metals studied. Only Cu was significantly affected
by BSE infection. The BSE caused an increase in Cu
level that was significant from the third dmth. The
values were first, 29 ± 4 ppm for BSE, 33 ± 4 for controls;
second, 35 ± 4 ppm for BSE, 33 ± 3 ppm for controls;
third, 48 ± 3 ppm for BSE, 23 ± 1 ppb for controls;
fourth, 43 ± 3 ppm for BSE, 20 ± 1 ppm for controls; and
fifth, 37 ± 3 for BSE, 24 ± 4 for controls. The average
values for the other metals measured for liver from
BSE-infected cattle were: Mn, 2.5 ± 0.3 ppm; Zn, 0.58
± 0.9 ppm; Se, 0.54 ± 0.08 ppb; Mo, 0.91 ± 0.08 ppb;
and Fe, 1.15 ± 0.22 ppm.
Metal levels were also measured in muscle (triceps
femoris) from BSE-infected animals and controls (Fig-
ure 3). There was no significant difference between con-
trols and BSE-infected cows for any metal studied.
Analysis of metals in the controls showed no significant
change throughout the time course of the experiment.
The exception was Fe that increased with age. The Fe
levels increased from 0.223 ± 0.031 ppm in the first
dmth to 0.523 ± 0.065 ppm in the fifth dmth. In BSE-
infected cattle, Fe increased from 0.245 ± 0.045 ppm in
the first dmth to 0.487 ± 0.069 ppm in the fifth dmth.
The average levels for the controls for the other metals
were Cu, 18.24 ± 3.12 ppm; Mn, 2.4 ± 0.3 ppb; Zn, 0.62
± 0.05 ppm; Se, 4.2 ± 0.3 ppb; and Mo, 0.35 ± 0.08 ppb.
The values for BSE were Cu, 1,412 ± 423 ppb; Mn, 2.5
± 0.4 ppb; Zn, 0.58 ± 0.06 ppm; Se, 4.3 ± 0.06 ppb; and
Mo, 0.29 ± 0.06 ppb. These results suggest BSE does
not alter metal metabolism in muscle.
Lastly, the metal content of blood from BSE and con-
trol animals was also studied (Figure 4). The levels of all
metals studied in control animals showed no significant
change over the course of the experiment. The only
metal that showed a change during the course of BSE
was Mn. The difference was significant from the third
dmth onward. The average values for Mn by dmth were:
first, 58 ± 12 ppb for BSE, 47 ± 3 ppb for controls;
second, 75 ± 14 ppb for BSE, 56 ± 8 ppb for controls;
third, 112 ± 23 ppb for BSE and 57 ± 8 ppb for controls,
fourth, 134 ± 35 ppb for BSE, 23 ± 2 for controls; and
fifth, 87 ± 12 ppb for BSE and 21 ± 3 ppb for controls.
In the fifth dmth, the BSE-challenged animals showed
a significant decrease in the level of Mn when compared
with the fourth dmth in the BSE-challenged animals.
The average levels for the other metals were Cu, 1,023
± 45 ppb for BSE, 1,123 ± 40 ppb for controls; Zn, 2,945
± 145 ppb for BSE and 3012 ± 122 ppb for controls; Se,
259 ± 27 ppb for BSE, 281 ± 34 ppb for controls; Mo,
89 ± 18 ppb for BSE, 81 ± 21 ppb for controls; and Fe,
309 ± 21 ppm for BSE, 312 ± 17 ppm for controls.
Experimental Scrapie
Although analysis of CNS tissue from field cases of
scrapie revealed some changes for Mn concentrations,
there was also evidence for changes in blood. Therefore
we also examined changes in blood metals during the
incubation period for scrapie in sheep experimentally
infected with a scrapie inoculum. Sheep with 3 different
genotypes were studied. These were ARR/ARR and
VRQ/VRQ homozygotes and VRQ/ARR heterozygotes.
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Figure 2. Samples of spinal cord from cattle infected with BSE () or age-matched controls () were digested to
atomic components and assessed formetal content using inductively coupled plasmamass spectroscopy. The individual
values were plotted to show the range of values for each time point. Concentrations of Cu (A), Mn (B), Zn (C), Se
(D), Mo (E), and Fe (F) are plotted according to the age of the animal at the time of culling. Values are either in parts
per billion (ppb) or parts per million (ppm). n = 9 to 16 for each decamonth. Arrowhead indicates approximate time
of onset of clinical signs.
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Figure 3. Samples of liver (A, C, E) or biceps femoris (B, D, F) from cattle infected with BSE () or age-matched
controls () were digested to atomic components and assessed for metal content using inductively coupled plasma
mass spectroscopy. The individual values were plotted to show the range of values for each time point. Concentrations
of Cu (A-B), Mn (C-D), and Fe (E-F) are plotted according to the age of the animal at the time of culling. Values are
either in parts per billion (ppb) or parts per million (ppm). n = 6 to 9 for each decamonth. Arrowhead indicates
approximate time of onset of clinical signs.
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Figure 4. Samples of blood from cattle infected with BSE () or age-matched controls () were digested to atomic
components and assessed for metal content using inductively coupled plasma mass spectroscopy. The individual
values were plotted to show the range of values for each time point. Concentrations of Cu (A), Mn (B), Zn (C), Se
(D), Mo (E), and Fe (F) are plotted according to the age of the animal at the time of culling. Values are either in parts
per billion (ppb) or parts per million (ppm). n = 9 to 14 for each decamonth. Arrowhead indicates approximate time
of onset of clinical signs.
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Blood samples were collected and analyzed as before.
It should be noted that blood sampling was performed
on different sheep because sheep were culled at each
time point. For statistical purpose, samples were con-
sidered independent. All samples were collected in the
preclinical phase of the infection. The ARR/ARR do not
develop scrapie and are considered resistant. The geno-
type of the sheep did not affect the levels of the metals
studied (Figure 5 for Mn and Cu, other metals not
shown). Scrapie infection caused changes in only 2 of
the metals, Cu and Mn. Changes in Mn were observed
in all genotypes, but changes in Cu were only observed
in the VRQ/VRQ and VRQ/ARR sheep. The Mn values
for the 3 genotypes after scrapie infection were com-
pared using ANOVA. The values for scrapie for the 3
genotypes were not significantly different for compara-
ble time points (P = 0.1). However, these values were
significantly different (P < 0.001) to the combined con-
trols (all 3 genotypes) for all time points from 25 d and
above. This implies that scrapie infection alters Mn
levels in sheep blood regardless of the genotype and
apparent resistance to the disease.
Due to the small number of samples available we
combined values for the 3 genotypes up to 150 d for the
statistical analysis (Table 3). Values for Mo increase
with time but were not affected by scrapie. Values for
Cu indicated that scrapie causes a significant increase
in Cu levels in blood at 150 d post challenge. However,
as indicated above scrapie causes an increase in blood
Mn from 50 d post challenge. These results differ from
that of field cases of scrapie in that Mo and Se levels
were not altered by scrapie. However, changes in blood
Mn and Cu are present in the blood of scrapie-infected
animals regardless of the initial cause of the disease,
the genotype of the sheep, or the degree of resistance
to the disease.
DISCUSSION
The main purpose of this study was to investigate
changes in metals in tissues from animals with BSE
or scrapie. This investigation was prompted by results
from studies with scrapie-infected mice that suggested
a TSE infection alters the levels of Mn in the brain and
blood (Thackray et al., 2002). The results of this study
confirm those findings. We have studied the concentra-
tion of metals in cattle and sheep with either naturally
occurring (field cases) or experimental TSE. The most
consistent findings in this study were the elevation of
Mn and the decrease in the levels of Cu in blood and
regions of the CNS of animals with a TSE. The data
have been presented to show the range and variability
of the levels of all metals studied. Data presented this
way indicate that although levels of Mn can be elevated,
not all individuals studied will show an elevated blood
or brain Mn. However, on average the results consis-
tently and robustly demonstrate that elevated Mn is
an indicator and thus a possible surrogate marker for
the presence of a TSE infection.
One of the most interesting findings from this study
was the analysis of ARR/ARR sheep blood. A similar
change in blood Mn was seen with these animals follow-
ing scrapie challenge as was seen with VRQ/VRQ sheep
challenged with the same agent. Because these sheep
are resistant to scrapie (i.e., do not develop the disease
symptoms of scrapie), this implies that the change in
blood Mn is a result of the scrapie challenge and is
not a consequence of scrapie pathology. The immediate
consequence of this finding is that although ARR/ARR
sheep are considered to be resistant to scrapie, they do
show some indications that scrapie challenge results
in similar metabolic changes as occur in nonresistant
sheep. It should be noted that although scrapie-resis-
tant sheep do not show symptoms of disease or pathol-
ogy, in some instances challenge of resistant sheep does
result in the presence of protease-resistant PrP in vari-
ous tissues including the brain (Buschmann et al., 2004;
Madec et al., 2004; Gonzalez et al., 2005; Le Dur et
al., 2005).
The analysis of bovine blood produced similar results
to the blood from sheep. Once again Mn was altered.
The change in Mn was dramatic, and the change fol-
lowed roughly a bell shape, occurring before onset of
symptoms (at 27 to 29 mo), peaking well before the
terminal stage of the disease, but declining again. These
changes also suggest the elevation in Mn does not result
from the major pathological changes but is a conse-
quence of the infection. In experimental BSE there were
no other significant changes in blood metals. In the field
cases of BSE and scrapie, there were changes in Se and
Mo. Both metals were decreased in the TSE-infected
animals. The difference between experimental and field
cases of these diseases suggests a difference in the ac-
quisition of the disease or possibly difference in suscep-
tibility of animals to TSE. The decreased levels of Mo
and Se may not have been due to the TSE infection
under natural conditions. Animals with decreased Se
and Mo levels could be inherently more susceptible to
scrapie or BSE.
Changes in the metal content of the brain have been
previously observed in both CJD and experimental
mouse scrapie (Wong et al., 2001; Thackray et al., 2002).
In this study 2 to 3 separate areas of the CNS were
studied. As before, the most common changes were in
Mn, but the changes observed were regionally re-
stricted. The changes were most commonly associated
with those brain regions in which TSE pathology occurs
such as the brain stem in scrapie and the spinal cord
in BSE (Wells et al., 1988; Scott et al., 1992; Begara-
McGorum et al., 2002; Ersdal et al., 2003; Vidal et al.,
2005). In some cases of scrapie there are also changes
in the cerebellum, sometimes without changes in other
brain regions. In our study, cerebellum showed some
changes in Mn levels. In comparison, the frontal cortex
showed no changes in Mn in scrapie or BSE. As in blood,
experimental BSE verified that the changes in spinal
cord Mn occurred before onset of clinical signs. This
suggests that changes in Mn in the CNS are not neces-
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Figure 5. Blood samples from sheep experimentally infected with scrapie () collected at specific time points after
infection. Samples from control, age-matched sheep were also collected (). The sheep were homozygous for the
prion protein of the allele known as VRQ (A-B), heterozygous ARR/VRQ (C-D), or homozygous ARR (E-F). The
blood samples were digested to atomic components and assessed for metal content using inductively coupled plasma
mass spectroscopy. The individual values were plotted to show the range of values for each time point. n = 2 for
controls and n = 4 for scrapie-challenged sheep for each time point. Concentrations of Cu (A, C, E) and Mn (B, D, F)
are plotted according to the time after oral challenge. Values are in parts per billion (ppb).
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Table 3. Concentrations of metals in blood from experimental scrapie1
Mn Cu Zn Fe Mo Se
Days Con Sc Con Sc Con Sc Con Sc Con Sc Con Sc
10 31 ± 3 31 ± 1 935 ± 124 921 ± 98 1.3 ± 0.2 1.4 ± 0.1 27 ± 2 28 ± 2 31 ± 1 28 ± 2 365 ± 23 366 ± 35
25 27 ± 2 34 ± 2* 972 ± 205 902 ± 78 1.3 ± 0.2 1.3 ± 0.2 30 ± 1 31 ± 2 36 ± 2 40 ± 2 373 ± 34 360 ± 33
50 31 ± 2 46 ± 3* 933 ± 178 920 ± 123 1.4 ± 0.1 1.3 ± 0.3 34 ± 2 30 ± 1 50 ± 2+ 44 ± 3 392 ± 37 366 ± 35
75 31 ± 3 51 ± 4* 970 ± 98 973 ± 91 1.3 ± 0.1 1.3 ± 0.2 30 ± 3 34 ± 1 54 ± 3+ 61 ± 2 385 ± 41 360 ± 29
100 28 ± 4 49 ± 4* 965 ± 134 1,083 ± 76* 1.4 ± 0.2 1.4 ± 0.3 28 ± 2 28 ± 2 79 ± 4+ 73 ± 4 387 ± 24 407 ± 38
150 29 ± 3 50 ± 4* 989 ± 106 1,120 ± 45* 1.4 ± 0.2 1.3 ± 0.2 27 ± 1 32 ± 1 79 ± 4+ 75 ± 3 421 ± 36 403 ± 35
1Con = control; Sc = Scrapie.
*Significant difference from control value, + = significantly different from d 10 value (controls only). n = 9 for scrapie-challenged sheep,
and n = 6 for controls.
sarily a result of pathological changes associated with
the BSE. Indeed, because the increased Mn is signifi-
cant at around 20 mo of age (15 mo into the incubation
period), these changes are potentially an early sign of
BSE infection and are indicative that the regional na-
ture of BSE pathology could be determined at this
early stage.
Field cases of TSE all show changes in Cu throughout
the regions analyzed. This indicates the change is not
specific for any particular CNS region. The decrease in
CNS Cu levels was accompanied by a similar increase
in the Cu concentrations of the liver. Changes in Cu
levels in the brain are frequently accompanied by
changes in liver Cu, and such a change was noted for
scrapie infected mice (Thackray et al., 2002). This is
suggestive of a decreased intake or retention of Cu by
the brain.
Other changes in metals in the CNS are less consis-
tent. Molybdenum and Se are only altered in the cere-
bellum of scrapie field cases but not of BSE field cases.
In experimental BSE only Mo was altered in the frontal
cortex. The inconsistencies in these findings suggest
that they might not be directly related to BSE or scrapie
infection. In the case of BSE they might be related to
the way in which the cattle were farmed. In the field
cases of scrapie, as suggested for blood, these differ-
ences could be simply a by-product of selection for
scrapie sensitivity.
Both liver and muscle are tissues with low or no prion
protein expression and show no pathological changes
in response to a TSE challenge. Therefore, as expected,
there were no changes in these tissues other than the
change in liver Cu as already mentioned.
This study also prevents a detailed analysis of trace
elements in cattle for various tissues throughout the
first 4 yr of life. The levels measured for most metals
in the different tissues showed only small variance.
This attests to the accuracy and reproducibility of the
measurements. This implies that these results could be
used as a standard reference for metal concentrations
in cattle using modern techniques. Although metals in
the tissues of animals have been studied for many
years, it was not possible to source or gain access to a
standard reference set of metals in cattle or sheep to
compare with this study. Those publications we could
access (e.g., Boyer et al., 1981; Erdogan et al., 2004;
Miranda et al., 2006) provided only limited information
on small number of animals but largely correlated well
with our findings.
The origin of the increased Mn in the brains and
blood of TSE-infected animals remains unknown. The
3 possibilities are that there is decreased secretion of
Mn from the body, release of Mn from other tissues,
or increased absorption of Mn from the environment.
Currently, there is no evidence to clearly support any
of these 3 possibilities. Several studies have linked ele-
vated Mn in the soil with increased incidence of some
TSE (Ragnarsdottir and Hawkins, 2005; Roman-Rosser
et al., 2006). The 2 possible entry routes for increased
Mn entry into the body from the soil are absorption
through the diet or absorption through the respiratory
and olfactory mucosae. The mechanism of entry of Mn
into the body via the lungs is still unknown. In mangan-
ism, a disease common among Mn miners, Mn is ab-
sorbed through the lungs (Scholten, 1953; Roth, 2006).
The amount of Mn in the diet is several orders of magni-
tude higher than the amount absorbed through the gut.
Therefore, it is very unlikely that Mn absorption
through this route would have any significant effect
on blood Mn levels. Therefore, absorption through the
respiratory system, the known route of entry of excess
Mn into the body, is the likely source of any possible
increased Mn uptake/retention from the environment.
It should be noted that in experimental cases of BSE
and scrapie the elevation in Mn occurs independently
of any increased Mn in the environment. In this case
the change in Mn occurs as a result of the TSE infection.
The elevated Mn is more likely to come from increased
absorption or retention of Mn rather than an increased
availability from an environmental source.
Manganese binding to PrP is known to cause a confor-
mational change in the protein (Brown et al., 2000).
Therefore, increased brain Mn is likely to create an
environment that would potentiate the rate of PrP con-
version to the abnormal isoform. However, as it is well
documented that the interaction between PrPSc and
PrPc induced the conversion to PrPSc in experimental
TSE infections. It is nevertheless intriguing to specu-
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late that prion infection could initially alter Mn metabo-
lism in the brain, which could in turn initiate conversion
of host PrPc to the abnormal isoform without the need
for direct interaction between the introduced PrPSc and
the host protein. These suggestions concerning experi-
mental infection do not rule out the possibility that
sporadic prion diseases could be triggered by a metal
imbalance as previously suggested (Brown et al., 2001),
although on the balance of probabilities, it is more likely
that metal imbalances represent a risk factor than a
causative agent. Indeed, despite the high correlation
between increased Mn concentrations in CNS or blood,
it is possible that elevated Mn is a result of TSE chal-
lenge and is not at all related to protein conversion or
disease progress. Nevertheless, the results presented
here verify the potential of elevated Mn to be a surro-
gate marker for prion infection. Any further relation-
ship between Mn and disease progress requires further
investigation of the links between Mn and prion pro-
tein metabolism.
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